Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.

Overview of attention for article published in Clinical Cancer Research, September 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 4 Mendeley

Summary Blogs Dimensions citations

So far, Altmetric has seen 1 blog post.

Immunotherapy-resistant Renal Cell Carcinoma Patients Without Fumarate Hydrase

Physician's Weekly, 30 Nov 2022

The critical need for effective therapy of fumarate hydratase-deficient renal cell carcinoma (FHRCC) is currently unmet.

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.